Long and noncoding RNAs (lnc-RNAs) determine androgen receptor dependent gene expression in prostate cancer growth in vivo

Asian Journal of Andrology

Volumn 16, Issue 2, 2014, Pages 268-269

  Pestell, Richard G ^a   Yu, Zuoren ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; LONG UNTRANSLATED RNA; PROSTATE CANCER ANDROGEN 3; PROSTATE CANCER GENE EXPRESSION MARKER 1; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

CANCER CELL; CANCER GROWTH; CELL PROLIFERATION; EPIGENETICS; GENE EXPRESSION; IN VIVO STUDY; PROSTATE CANCER; RECEPTOR GENE; SHORT SURVEY; URINE LEVEL;

ANIMALS; HUMANS; MALE; RECEPTORS, ANDROGEN; RNA, LONG NONCODING; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 84896769949     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.4103/1008-682X.122364     Document Type: Short Survey

References (15)

1. Yang L, Lin C, Jin C, Yang JC, Tanasa B, et al. lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs. Nature 2013; 500: 598-602.
2. Leader JE, Wang C, Fu M, Pestell RG. Epigenetic regulation of nuclear steroid receptors. Biochem Pharmacol 2006; 72: 1589-96. (Pubitemid 44666731)
3. Fu M, Wang C, Reutens AT, Wang J, Angeletti RH, et al. p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation. J Biol Chem 2000; 275: 20853-60. (Pubitemid 30457679)
4. Gong J, Zhu J, Goodman OB Jr., Pestell RG, Schlegel PN, et al. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells. Oncogene 2006; 25: 2011-21.
5. Fu M, Rao M, Wu K, Wang C, Zhang X, et al. The androgen receptor acetylation site regulates cAMP and AKT but not ERK-induced activity. J Biol Chem 2004; 279: 29436-49. (Pubitemid 38915823)
6. Fu M, Liu M, Sauve AA, Jiao X, Zhang X, et al. Hormonal control of androgen receptor function through SIRT1. Mol Cell Biol 2006; 26: 8122-35. (Pubitemid 44631010)
7. Wu K, Katiyar S, Witkiewicz A, Li A, McCue P, et al. The cell fate determination factor dachshund inhibits androgen receptor signaling and prostate cancer cellular growth. Cancer Res 2009; 69: 3347-55.
8. Fu M, Wang C, Wang J, Zhang X, Sakamaki T, et al. Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function. Mol Cell Biol 2002; 22: 3373-88. (Pubitemid 34453978)
9. Fu M, Rao M, Wang C, Sakamaki T, Wang J, et al. Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth. Mol Cell Biol 2003; 23: 8563-75. (Pubitemid 37433362)
10. Cabili MN, Trapnell C, Goff L, Koziol M, Tazon-Vega B, et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev 2011; 25: 1915-27.
11. Prensner JR, Chinnaiyan AM. The emergence of lncRNAs in cancer biology. Cancer Discov 2011; 1: 39-407.
12. Cheng W, Zhang Z, Wang J. Long noncoding RNAs: New players in prostate cancer. Cancer Lett 2013; 339: 8-14.
13. Bussemakers MJ, van Bokhoven A, Verhaegh GW, Smit FP, Karthaus HF, et al. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res 1999; 59: 5975-9. (Pubitemid 30004960)
14. Petrovics G, Zhang W, Makarem M, Street JP, Connelly R, et al. Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients. Oncogene 2004; 23: 605-11. (Pubitemid 38175016)
15. Louro R, Nakaya HI, Amaral PP, Festa F, Sogayar MC, et al. Androgen responsive intronic non-coding RNAs. BMC Biol 2007; 5: 4.